OpenVSafe by OpenVAERS
Search V-safe

AYL-28678-60440

3 vaccinations 4 coded responses 16 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
840 / UT
Registered
2022-09-01
Relationship
Child or adolescent in my care
Guardian
5E6-78892-45171
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-08-30
    Dose 1 — Pfizer-BioNTech
  2. 2022-09-01
    Registered in v-safe
  3. 2022-09-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  4. 2022-09-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  5. 2022-09-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-06
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-09-20
    Survey response — day 21, dose 1, under 3
    MedDRA: Fungal infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Yeast infection
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-09-20
    Report sent to call center — day 21, dose 1, under 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  9. 2022-09-21
  10. 2022-09-27
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-09-28
    Dose 2 — Pfizer-BioNTech
  12. 2022-09-29
    Dose 3 — Pfizer-BioNTech
  13. 2022-10-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-10-05
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-10-12
    Survey response — day 14, dose 2, under 3
    MedDRA: Nasal crusting, Rhinorrhoea — Feeling: Good
    Free text: Crusty, slightly runny nose today
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-10-19
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-10-26
    Health check-in — day 28, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  18. 2022-11-02
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-11-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-12-30
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-12-30
    Survey response — 3 months, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school
    Free text: Like a cold
    MedDRA releases: 2024-11 · check-in free text available
  22. 2023-03-30
    Survey response — 6 months, dose 3, under 3
    MedDRA: Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-08-30Pfizer-BioNTech No
22022-09-28Pfizer-BioNTech No
32022-09-29Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-09-20 Unsuccessful

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-09-20

Symptoms: Yeast infection

Release 12 (Under 3) — day 14, dose 2, under 3

2022-10-12

Symptoms: Crusty, slightly runny nose today

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-30

Symptoms: Like a cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFungal infection · · ✓
SDNasal crusting · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release